298 related articles for article (PubMed ID: 34678727)
1. Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19.
Koushki K; Salemi M; Miri SM; Arjeini Y; Keshavarz M; Ghaemi A
Biomed Pharmacother; 2021 Dec; 144():112346. PubMed ID: 34678727
[TBL] [Abstract][Full Text] [Related]
2. Myeloid-Derived Suppressor Cells in
Fresno M; Gironès N
Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
[TBL] [Abstract][Full Text] [Related]
3. Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good.
Grassi G; Notari S; Gili S; Bordoni V; Casetti R; Cimini E; Tartaglia E; Mariotti D; Agrati C; Sacchi A
Front Immunol; 2022; 13():842949. PubMed ID: 35572540
[TBL] [Abstract][Full Text] [Related]
4. Correlation of myeloid-derived suppressor cells with C-reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID-19.
Emsen A; Sumer S; Tulek B; Cizmecioglu H; Vatansev H; Goktepe MH; Kanat F; Koksal Y; Arslan U; Artac H
Scand J Immunol; 2022 Jan; 95(1):e13108. PubMed ID: 34625989
[TBL] [Abstract][Full Text] [Related]
5. Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
Jiménez-Cortegana C; Sánchez-Jiménez F; Pérez-Pérez A; Álvarez N; Sousa A; Cantón-Bulnes L; Vilariño-García T; Fuentes S; Martín S; Jiménez M; León-Justel A; de la Cruz-Merino L; Garnacho-Montero J; Sánchez-Margalet V
Front Immunol; 2021; 12():801410. PubMed ID: 35154077
[TBL] [Abstract][Full Text] [Related]
6. Respiratory and systemic monocytes, dendritic cells, and myeloid-derived suppressor cells in COVID-19: Implications for disease severity.
Falck-Jones S; Österberg B; Smed-Sörensen A
J Intern Med; 2023 Feb; 293(2):130-143. PubMed ID: 35996885
[TBL] [Abstract][Full Text] [Related]
7. Elevated frequencies of CD14
Xue G; Jiang M; Zhao R; Le A; Li J
Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
[TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of IFN-γ-induced M-MDSCs promotes immune tolerance to allografts through iNOS pathway.
Yang F; Li Y; Zou W; Xu Y; Wang H; Wang W; Zhao Y
Inflamm Res; 2019 Jul; 68(7):545-555. PubMed ID: 31055608
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
10. Monocytic myeloid-derived suppressor cells regulate T-cell responses against vaccinia virus.
Fortin C; Yang Y; Huang X
Eur J Immunol; 2017 Jun; 47(6):1022-1031. PubMed ID: 28383204
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective Role of Myeloid-Derived Suppressor Cells in Heart Failure.
Zhou L; Miao K; Yin B; Li H; Fan J; Zhu Y; Ba H; Zhang Z; Chen F; Wang J; Zhao C; Li Z; Wang DW
Circulation; 2018 Jul; 138(2):181-197. PubMed ID: 29437117
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients.
Kiaee F; Jamaati H; Shahi H; Roofchayee ND; Varahram M; Folkerts G; Garssen J; Adcock IM; Mortaz E
Sci Rep; 2022 Dec; 12(1):22570. PubMed ID: 36581679
[TBL] [Abstract][Full Text] [Related]
13. New Discovery of Myeloid-Derived Suppressor Cell's Tale on Viral Infection and COVID-19.
Park SJ; Nam DE; Seong HC; Hahn YS
Front Immunol; 2022; 13():842535. PubMed ID: 35185933
[TBL] [Abstract][Full Text] [Related]
14. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19).
Agrati C; Sacchi A; Bordoni V; Cimini E; Notari S; Grassi G; Casetti R; Tartaglia E; Lalle E; D'Abramo A; Castilletti C; Marchioni L; Shi Y; Mariano A; Song JW; Zhang JY; Wang FS; Zhang C; Fimia GM; Capobianchi MR; Piacentini M; Antinori A; Nicastri E; Maeurer M; Zumla A; Ippolito G
Cell Death Differ; 2020 Nov; 27(11):3196-3207. PubMed ID: 32514047
[TBL] [Abstract][Full Text] [Related]
15. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
Jiang Y; Feng S; Ji J; Lin Z; Zhang X
Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19.
Rowlands M; Segal F; Hartl D
Front Immunol; 2021; 12():697405. PubMed ID: 34220859
[TBL] [Abstract][Full Text] [Related]
17. Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19.
Alsalman A; Al-Mterin MA; Elkord E
J Immunol Res; 2022; 2022():5545319. PubMed ID: 35497875
[TBL] [Abstract][Full Text] [Related]
18. TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide.
Yang F; Li Y; Wu T; Na N; Zhao Y; Li W; Han C; Zhang L; Lu J; Zhao Y
J Mol Med (Berl); 2016 Aug; 94(8):911-20. PubMed ID: 26936474
[TBL] [Abstract][Full Text] [Related]
19. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.
Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y
Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271
[TBL] [Abstract][Full Text] [Related]
20. Myeloid-derived suppressor cells in COVID-19: A review.
Perfilyeva YV; Ostapchuk YO; Tleulieva R; Kali A; Abdolla N; Krasnoshtanov VK; Perfilyeva AV; Belyaev NN
Clin Immunol; 2022 May; 238():109024. PubMed ID: 35489643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
